Related Experiment Video
Updated: May 21, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen)
Yongchol Shin1, Masashi Akiyama, Koichi Kokame
1Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan. shin@cc.kogakuin.ac.jp
Abstract:
The metalloprotease ADAMTS13 affects platelet adhesion and aggregation through depolymerization of von Willebrand factor (VWF) multimers. Identification of ADAMTS13-binding proteins would reveal the hitherto unrecognized mechanisms underlying microvascular thrombus. To identify ADAMTS13-binding proteins, we performed a yeast two-hybrid screen using the Cys-rich and spacer domains of ADAMTS13, the critical regions for the binding and cleavage of VWF, as a bait region. We identified Lys-plasminogen, an amino-terminal truncated form of plasminogen, as the binding protein to ADAMTS13. Intact Glu-plasminogen did not bind to ADAMTS13. Active-site blocked Lys-plasmin bound to ADAMTS13. Domain truncation of ADAMTS13 and elastase digest of plasminogen indicated that the Cys-rich and spacer domains of ADAMTS13 and the kringle 5 and protease domains of plasminogen served as the main binding sites. Biacore measurements revealed that Lys-plasminogen bound to ADAMTS13 with a K(d) of 1.9 ± 0.1 × 10(-7) M and Glu-plasminogen exhibited a significantly lower affinity to ADAMTS13. Specific activity measurements revealed that ADAMTS13 and Lys-plasmin were still active even after the binary complex was formed. The binding of ADAMTS13 to Lys-plasminogen may play an important role to localize these two proteases at sites of thrombus formation or vascular injury where the fibrinolytic system is activated.
Insights
ADAMTS13 protease binds Lys-plasminogen, a truncated form of plasminogen, but not intact plasminogen. This interaction may localize these proteases to sites of thrombus formation and vascular injury.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- The metalloprotease ADAMTS13 is crucial for regulating platelet aggregation by cleaving von Willebrand factor (VWF) multimers.
- Understanding proteins that bind ADAMTS13 is key to uncovering mechanisms of microvascular thrombosis.
Purpose of the Study:
- To identify proteins that bind to ADAMTS13.
- To characterize the binding interaction between ADAMTS13 and its identified binding partners.
Main Methods:
- Yeast two-hybrid screening using specific domains of ADAMTS13 as bait.
- Domain truncation analysis of ADAMTS13 and plasminogen.
- Elastase digestion of plasminogen.
- Biacore assays for binding affinity measurements.
- Specific activity assays for protease function.
Main Results:
- Lys-plasminogen, but not intact Glu-plasminogen, was identified as an ADAMTS13-binding protein.
- The Cys-rich and spacer domains of ADAMTS13 and the kringle 5 and protease domains of plasminogen are key binding sites.
- Lys-plasminogen binds ADAMTS13 with a K(d) of 1.9 × 10(-7) M, significantly higher affinity than Glu-plasminogen.
- Both ADAMTS13 and Lys-plasmin retain activity after complex formation.
Conclusions:
- ADAMTS13 specifically binds Lys-plasminogen, suggesting a novel regulatory role.
- This interaction may localize ADAMTS13 and Lys-plasminogen to sites of thrombus formation or vascular injury.
- The binding facilitates the localization of these proteases within the activated fibrinolytic system during thrombosis.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Vascular Spasm

